Effect of apotel injection on opioid consumptio
Phase 2
Completed
- Conditions
- Post-operative pain control.Acute pain
- Registration Number
- IRCT201701258375N11
- Lead Sponsor
- Research deputy Birjand University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inguinal hernia; surgical candidate for ASA classes 1 and 2; age 20-50 years
Exclusion criteria: drug addiction; history of chronic diseases, diabetes, heart failure, hypertension etc; neuropsychological diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean of opioid consumption. Timepoint: 1, 2, 4, 8, 12 and 24 hours after surgery. Method of measurement: mg/kg.
- Secondary Outcome Measures
Name Time Method Pain. Timepoint: 1, 2, 4, 8, 12 and 24 hours after surgery. Method of measurement: VAS.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does apotel injection target for post-operative pain control in herniorrhaphy patients?
How does preoperative apotel compare to standard-of-care opioid regimens in acute post-surgical pain management?
Are there specific biomarkers that predict response to apotel in reducing opioid consumption after hernia repair?
What adverse events are associated with apotel use in phase II trials for acute pain management?
What are the potential combination therapies involving apotel for improved post-operative analgesia in herniorrhaphy?